CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 26 enrolled
Drug / intervention
Ropivacaine 0.5%drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02541552
NCT02541552Phase 3Completed
CompareCT.gov

Effect of Volume of Local Anesthetic for Adductor Canal Block on Quadriceps Muscle Function: A Dose Finding Study

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·interventional·Posted Sep 4, 2015·Updated Aug 25, 2016

In Brief

A Phase 3 clinical trial evaluating Ropivacaine 0.5% for Postoperative Pain. Completed, enrolled 26 participants across 1 site.

Detailed Summary

Adductor canal block is commonly offered to provide pain relief following knee surgery with the hope that they cause less leg weakness than traditionally performed femoral nerve block. Infrequently, adductor canal blocks also result in leg weakness thereby potentially limiting the advantages of the technique. Investigators want to find out the effective dose for a 30% response (volume of local anesthetic which would result in clinically significant weakness of the leg)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesCanada
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 4, 2015
Enrollment StartApr 1, 2015
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.8 years ago

Interventions

Ropivacaine 0.5%drug

Varying volume according to motor response of previous subject